<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02131753</url>
  </required_header>
  <id_info>
    <org_study_id>NHL 3-2004</org_study_id>
    <nct_id>NCT02131753</nct_id>
  </id_info>
  <brief_title>Therapy Optimisation for the Treatment of Hairy Cell Leukemia</brief_title>
  <official_title>Therapy Optimisation for the Treatment of Hairy Cell Leukemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Giessen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Giessen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The trial will test the effectiveness and toxicity of subcutaneous treatment with one cycle
      of cladribine in patients with hairy cell leukemia requiring treatment.

      They have to be untreated so far or may be pretreated with alpha-interferon.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Evaluation of remission status will take place 4 months after treatment. In addition, it will
      be tested whether patients with non-optimal response will have a benefit from a second cycle
      of cladribine.

      Non-optimal response is: patients with detectable residual disease; achievement of partial
      remission or detectable residual infiltration in the bone marrow.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2004</start_date>
  <completion_date type="Anticipated">December 2027</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Determination of the rate of complete remissions after one cycle with subcutaneous cladribine</measure>
    <time_frame>4 months after treatment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of complete remissions in patient who still have detectable residual disease</measure>
    <time_frame>4 months after treatment</time_frame>
    <description>A second cycle of cladribine after an interval of 4 months following the first cycle.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Overall effectiveness</measure>
    <time_frame>20 years</time_frame>
    <description>Determination of:
overall remission rate
duration of remission
immunodeficiency induced by treatment, its duration, infectious and other complications resulting from that
frequency of secondary neoplasia during life long follow up
overall survival</description>
  </other_outcome>
  <other_outcome>
    <measure>Improvement of remission deepness</measure>
    <time_frame>Date of staging after first cycle + 4 months</time_frame>
    <description>Can a complete remission be achieved with a second cycle in patients who have achieved only a partial remission after one cycle?</description>
  </other_outcome>
  <other_outcome>
    <measure>Improvement of remission quality</measure>
    <time_frame>Date of staging after first cycle + 4 months</time_frame>
    <description>Can the quality of remission achieved with the first cycle be improved with a second cycle?</description>
  </other_outcome>
  <other_outcome>
    <measure>Lowering risk of relapse</measure>
    <time_frame>Date of proven remission until the date of firdt documented progression or date of death from any cause, whichever came first, assessed up to 20 years</time_frame>
    <description>Can the expected risk of relapse be lowered and the duration of remission be prolonged?</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">210</enrollment>
  <condition>Hairy Cell Leukemia</condition>
  <arm_group>
    <arm_group_label>Cladribine s.c. injection, HCL treatment</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Cladribine 0.14 mg/kg body weight for 5 consecutive days (d 1 - 5) as subcutaneous bolus injection for patients with hairy cell leukemia needing treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cladribine s.c. injection, HCL treatment</intervention_name>
    <description>Patients with hairy cell leukemia and the need for treatment are given cladribine 0.14 mg/kg for 5 consecutive days as a s. c bolus injection</description>
    <arm_group_label>Cladribine s.c. injection, HCL treatment</arm_group_label>
    <other_name>Litak(R)</other_name>
    <other_name>2-CdA</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with histologically verified hairy cell leukemia

          -  Presence of hairy cells in the bone marrow and peripheral blood detected by positive
             TRAP staining and / or co expression if cell surface antigens cluster of
             differentiation (CD) 19/CD25 or CD19/CD103 (b-ly7)

          -  No previous cytostatic treatment (splenectomy or interferon treatment are allowed)

          -  Need for treatment

          -  Age at least 18 years old

          -  General state of health according to WHO 0-2

          -  Current histology, not older than 6 months

          -  Written consent by patient

        Exclusion Criteria:

          -  Patients not fulfilling inclusion criteria above

          -  Hairy cell leukemia variants (HCL-V): presence of lymphoid cells in bone marrow and /
             or peripheral blood, which have an intermediate morphology between hairy cells and
             prolymphocytes (negative TRAP staining and co- expression of CD19/CD103 without CD25

          -  Pretreatment with purine analogues or other chemotherapeutics

          -  Concomitant corticosteroid therapy

          -  Severe dysfunction of the heart (NYHA III or IV), the lung (WHO-Grade III or IV), the
             liver, except due to lymphoma (bilirubin &gt; 2 mg/dl, alkaline phosphatase,
             glutamate-oxalacetate transaminase and glutamate-pyruvate transaminase &gt; 2 x upper
             limit of normal), the kidneys (creatinin &gt; 2 mg/dl or creatinine clearance &lt; 50
             ml/min), central nervous system diseases including psychoses.

          -  Proven HIV infection

          -  Active Hepatitis

          -  Other florid infections

          -  Anamnesis / diagnosis of other malignant disease (other than non-melanoma associated
             skin tumours or stage 0 in situ carcinoma of the cervix)

          -  Pregnant or lactating women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mathias J Rummel, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Justus-Liebig-University | University Hospital | Medicinal Clinic IV</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mathias J Rummel, Prof PhD</last_name>
    <phone>+4964198542</phone>
    <phone_ext>650</phone_ext>
    <email>mathias.rummel@innere.med.uni-giessen.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Juergen Barth</last_name>
    <phone>+4964198542</phone>
    <phone_ext>603</phone_ext>
    <email>juergen.barth@innere.med.uni-giessen.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Community based hemato-oncology medical office</name>
      <address>
        <city>Ansbach</city>
        <zip>91522</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sebastian Müller, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Sebastian Müller, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community based hemato-oncology medical office</name>
      <address>
        <city>Aschaffenburg</city>
        <zip>63739</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manfred Welslau, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Manfred Welslau, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rhön-Saale-Klinik gGmbH</name>
      <address>
        <city>Bad Neustadt</city>
        <zip>97616</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Klaus Wutke, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Klaus Wutke, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community based hemato-oncology medical office</name>
      <address>
        <city>Berlin</city>
        <zip>10407</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Herbert Lebahn, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Herbert Lebahn, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Charité - Universitätsmedizin Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>12203</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eckhard Thiel, Prof PhD</last_name>
    </contact>
    <investigator>
      <last_name>Eckhard Thiel, Prof PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community based hemato-oncology medical office</name>
      <address>
        <city>Bremen</city>
        <zip>28209</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karl Wietholt, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Karl Wietholt, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community based hemato-oncology medical office</name>
      <address>
        <city>Celle</city>
        <zip>29221</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Felix Marquard, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Felix Marquard, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community based hemato-oncology medical office</name>
      <address>
        <city>Cottbus</city>
        <zip>03046</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ulrich von Grünhagen, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Ulrich von Grünhagen, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community based hemato-oncology medical office</name>
      <address>
        <city>Darmstadt</city>
        <zip>64295</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Georgi Kojouharoff, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Georgi Kojouharoff, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community based hemato-oncology medical office</name>
      <address>
        <city>Dresden</city>
        <zip>01127</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Steffen Dörfel, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Steffen Dörfel, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community based hemato-oncology medical office</name>
      <address>
        <city>Duisburg</city>
        <zip>47166</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Johannes Selbach, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Johannes Selbach, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinik Duisburg-West</name>
      <address>
        <city>Duisburg</city>
        <zip>47228</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rüdiger Lang, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Rüdiger Lang, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinik Düsseldorf</name>
      <address>
        <city>Düsseldorf</city>
        <zip>40255</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guido Kobbe, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Guido Kobbe, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community based hemato-oncology medical office</name>
      <address>
        <city>Ehingen</city>
        <zip>89584</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Simon, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Martin Simon, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community based hemato-oncology medical office</name>
      <address>
        <city>Erlangen</city>
        <zip>91052</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael J Eckart, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Michael J Eckart, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community based hemato-oncology medical office</name>
      <address>
        <city>Frankfurt</city>
        <zip>60389</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wolfgang U Knauf, Prof PhD</last_name>
    </contact>
    <investigator>
      <last_name>Wolfgang U Knauf, Prof PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Krankenhaus Nordwest</name>
      <address>
        <city>Frankfurt</city>
        <zip>60488</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eckhart Weidmann, Prof PhD</last_name>
    </contact>
    <investigator>
      <last_name>Eckhart Weidmann, Prof PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community based hemato-oncology medical office</name>
      <address>
        <city>Freiburg</city>
        <zip>79106</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthias Zaiss, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Matthias Zaiss, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community based hemato-oncology medical office</name>
      <address>
        <city>Friedrichshafen</city>
        <zip>88045</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Helmut Oettle, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Helmut Oettle, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community based hemato-oncology medical office</name>
      <address>
        <city>Fürth</city>
        <zip>90766</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Harald Wagner, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Harald Wagner, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community based hemato-oncology medical office</name>
      <address>
        <city>Germering</city>
        <zip>82110</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Johann Mittermüller, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Johann Mittermüller, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community based hemato-oncology medical office</name>
      <address>
        <city>Gießen</city>
        <zip>35392</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Georg Ch Schließer, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Georg Ch Schließer, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Clinic | Medicinal Clinic IV</name>
      <address>
        <city>Gießen</city>
        <zip>35592</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mathias J Rummel, Prof. Dr.</last_name>
      <phone>+4964198542</phone>
      <phone_ext>650</phone_ext>
      <email>mathias.rummel@innere.med.uni-giessen.de</email>
    </contact>
    <contact_backup>
      <last_name>Juergen Barth</last_name>
      <phone>+4964198542</phone>
      <phone_ext>603</phone_ext>
      <email>juergen.barth@innere.med.uni-giessen.de</email>
    </contact_backup>
    <investigator>
      <last_name>Mathias J Rummel, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St.-Marien-Hospital</name>
      <address>
        <city>Hagen</city>
        <zip>58095</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>H W Lindemann, PhD</last_name>
    </contact>
    <investigator>
      <last_name>H W Lindemann, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community based hemato-oncology medical office</name>
      <address>
        <city>Halle</city>
        <zip>06110</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Rohrberg, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Robert Rohrberg, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Evangelisches Krankenhaus</name>
      <address>
        <city>Hamm</city>
        <zip>59063</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jörg Schubert, Prof PhD</last_name>
    </contact>
    <investigator>
      <last_name>Jörg Schubert, Prof PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community based hemato-oncology medical office</name>
      <address>
        <city>Hanau</city>
        <zip>63450</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gerd Lautenschläger, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Gerd Lautenschläger, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community based hemato-oncology medical office</name>
      <address>
        <city>Heidelberg</city>
        <zip>69115</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefan Fuxius, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Stefan Fuxius, Phd</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community based hemato-oncology medical office</name>
      <address>
        <city>Herne</city>
        <zip>44623</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lars Hahn, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Lars Hahn, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Marienkrankenhaus</name>
      <address>
        <city>Herne</city>
        <zip>44625</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dirk Strumberg, Prof PhD</last_name>
    </contact>
    <investigator>
      <last_name>Dirk Strumberg, Prof PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community based hemato-oncology medical office</name>
      <address>
        <city>Homberg / Efze</city>
        <zip>34626</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wolfgang Weber, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Wolfgang Weber, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community based hemato-oncology medical office</name>
      <address>
        <city>Kaiserslautern</city>
        <zip>67655</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manfred Reeb, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Manfred Reeb, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Städtisches Klinikum</name>
      <address>
        <city>Karlsruhe</city>
        <zip>76137</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Bentz, Prof. PhD</last_name>
    </contact>
    <investigator>
      <last_name>Martin Bentz, Prof. PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community based hemato-oncology medical office</name>
      <address>
        <city>Kassel</city>
        <zip>34117</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ulrike Söling, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Ulrike Söling, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum Kempten-Oberallgäu</name>
      <address>
        <city>Kempten</city>
        <zip>87439</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Otto Prümmer, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Otto Prümmer, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community based hemato-oncology medical office</name>
      <address>
        <city>Koblenz</city>
        <zip>56068</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rudolf Weide, Prof PhD</last_name>
    </contact>
    <investigator>
      <last_name>Rudolf Weide, Prof PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community based hemato-oncology medical office</name>
      <address>
        <city>Krefeld</city>
        <zip>47798</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Neise, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Michael Neise, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community based hemato-oncology medical office</name>
      <address>
        <city>Kronach</city>
        <zip>96317</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martina Stauch, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Stauch Martina, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community based hemato-oncology medical office</name>
      <address>
        <city>Landau</city>
        <zip>76829</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eva Huntenburg, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Eva Huntenburg, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community based hemato-oncology medical office</name>
      <address>
        <city>Landshut</city>
        <zip>84028</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ursula Vehling-Kaiser, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Ursula Vehling-Kaiser, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community based hemato-oncology medical office</name>
      <address>
        <city>Landshut</city>
        <zip>84034</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Barbara Kempf, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Barbara Kempf, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum Leverkusen GmbH</name>
      <address>
        <city>Leverkusen</city>
        <zip>51375</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Norbert Niederle, Prof PhD</last_name>
    </contact>
    <investigator>
      <last_name>Norbert Niederle, Prof PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Marienkrankenhaus</name>
      <address>
        <city>Ludwigshafen</city>
        <zip>67067</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>H Weiss, Prof PhD</last_name>
    </contact>
    <investigator>
      <last_name>H Weiss, Prof PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community based hemato-oncology medical office</name>
      <address>
        <city>Lüdenscheid</city>
        <zip>58507</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dietrich Kämpfe, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Dietrich Kämpfe, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinik Mainz</name>
      <address>
        <city>Mainz</city>
        <zip>55131</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Georg Heß, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Georg Heß, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community based hemato-oncology medical office</name>
      <address>
        <city>Marburg</city>
        <zip>35037</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christina Balser, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Christina Balser, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community based hemato-oncology medical office</name>
      <address>
        <city>Mönchengladbach</city>
        <zip>41239</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ulrich Grabenhorst, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Ulrich Grabenhorst, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community based hemato-oncology medical office</name>
      <address>
        <city>München</city>
        <zip>80335</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Bojko, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Peter Bojko, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Clinic Großhadern</name>
      <address>
        <city>München</city>
        <zip>81377</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Dreyling, Prof PhD</last_name>
    </contact>
    <investigator>
      <last_name>Martin Dreyling, Prof PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community based hemato-oncology medical office</name>
      <address>
        <city>Neumarkt</city>
        <zip>92318</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ekkehart Ladda, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Ekkehart Ladda, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community based hemato-oncology medical office</name>
      <address>
        <city>Nürnberg</city>
        <zip>90403</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Schauer, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Michael Schauer, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community based hemato-oncology medical office</name>
      <address>
        <city>Nürnberg</city>
        <zip>90449</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joachim Zimber, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Joachim Zimber, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Clemens Hospital</name>
      <address>
        <city>Oberhausen</city>
        <zip>46145</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jutta Schneider, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Jutta Schneider, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Martinus-Hospital</name>
      <address>
        <city>Olpe</city>
        <zip>57462</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clemens Müller-Naendrup, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Clemens Müller-Naendrup, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community based hemato-oncology medical office</name>
      <address>
        <city>Osnabrück</city>
        <zip>49074</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gertrud Lenzen, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Gertrud Lenzen, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Josefs-Krankenhaus</name>
      <address>
        <city>Potsdam</city>
        <zip>14471</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Göner, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Michael Göner, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community based hemato-oncology medical office</name>
      <address>
        <city>Rehling</city>
        <zip>86508</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephan Hochdörfer, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Stephan Hochdörfer, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community based hemato-oncology medical office</name>
      <address>
        <city>Rüsselsheim</city>
        <zip>65428</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Baldus, Phd</last_name>
    </contact>
    <investigator>
      <last_name>Michael Baldus, Phd</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Caritas Klinik St. Theresia</name>
      <address>
        <city>Saarbrücken</city>
        <zip>66113</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Axel Matzdorff, Prof PhD</last_name>
    </contact>
    <investigator>
      <last_name>Axel Matzdorff, Prof PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community based hemato-oncology medical office</name>
      <address>
        <city>Schkeuditz</city>
        <zip>04435</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Edelmann, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Thomas Edelmann, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kreiskrankenhaus Schotten</name>
      <address>
        <city>Schotten</city>
        <zip>63679</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>M Graubner, PhD</last_name>
    </contact>
    <investigator>
      <last_name>M Graubner, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community based hemato-oncology medical office</name>
      <address>
        <city>Schweinfurt</city>
        <zip>97421</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Reginhard von Hirschhausen, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Reginhard von Hirschhausen, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community based hemato-oncology medical office</name>
      <address>
        <city>Siegen</city>
        <zip>57072</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>F A Trux, PhD</last_name>
    </contact>
    <investigator>
      <last_name>F A Trux, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St.-Marien-Krankenhaus</name>
      <address>
        <city>Siegen</city>
        <zip>57072</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Winfried Gassmann, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Winfried Gassmann, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Diakonie - Klinikum Stuttgart</name>
      <address>
        <city>Stuttgart</city>
        <zip>70176</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Else Heidemann, Prof PhD</last_name>
    </contact>
    <investigator>
      <last_name>Else Heidemann, Prof. PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community based hemato-oncology medical office</name>
      <address>
        <city>Trier</city>
        <zip>54290</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hans P Laubenstein, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Hans P Laubenstein, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community based hemato-oncology medical office</name>
      <address>
        <city>Tübingen</city>
        <zip>72072</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Swen H Jacki, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Swen H Jacki, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Clinic Ulm</name>
      <address>
        <city>Ulm</city>
        <zip>89081</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Buske, Prof PhD</last_name>
    </contact>
    <investigator>
      <last_name>Christian Buske, Prof PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Städtisches Krankenhaus Villingen</name>
      <address>
        <city>Villingen-Schwenningen</city>
        <zip>78050</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wolfram Brugger, Prof PhD</last_name>
    </contact>
    <investigator>
      <last_name>Wolfram Brugger, Prof. PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community based hemato-oncology medical office</name>
      <address>
        <city>Weilheim</city>
        <zip>82362</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Sandherr, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Michael Sandherr, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sophien- und Hufeland Klinikum</name>
      <address>
        <city>Weimar</city>
        <zip>99425</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Hoffmann, Phd</last_name>
    </contact>
    <investigator>
      <last_name>Thomas Hoffmann, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Asklepios Nordseeklinik</name>
      <address>
        <city>Westerland</city>
        <zip>25980</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Willy Nettekoven, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Willy Nettekoven, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community based hemato-oncology medical office</name>
      <address>
        <city>Wiesbaden</city>
        <zip>65191</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Klaus M Josten, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Klaus M Josten, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dr. Horst-Schmidt-Kliniken</name>
      <address>
        <city>Wiesbaden</city>
        <zip>65199</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Norbert Frickhofen, Prof PhD</last_name>
    </contact>
    <investigator>
      <last_name>Norbert Frickhofen, Prof PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community based hemato-oncology medical office</name>
      <address>
        <city>Wilhelmshaven</city>
        <zip>26389</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yolanda Rodemer, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Yolanda Rodemer, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community based hemato-oncology medical office</name>
      <address>
        <city>Wolfsburg</city>
        <zip>38440</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joachim Haessner, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Joachim Haessner, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://www.stil-info.de/index.php?id=258</url>
    <description>Homepage of StiL = Study group indolent Lymphomas</description>
  </link>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 30, 2014</study_first_submitted>
  <study_first_submitted_qc>May 2, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 6, 2014</study_first_posted>
  <last_update_submitted>January 11, 2018</last_update_submitted>
  <last_update_submitted_qc>January 11, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Giessen</investigator_affiliation>
    <investigator_full_name>Jurgen Barth</investigator_full_name>
    <investigator_title>Head of StiL Coordinating Center</investigator_title>
  </responsible_party>
  <keyword>hairy cell leukemia</keyword>
  <keyword>untreated</keyword>
  <keyword>cladribine subcutaneous</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Leukemia</mesh_term>
    <mesh_term>Leukemia, Hairy Cell</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cladribine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

